The Clinical and Rehabilitative Medicine Research Program (CRMRP) is offering the Regenerative Medicine Clinical Trial Award (RMCTA) to support Phase I or II clinical trials. This grant is specifically for advancing regenerative medicine in critical areas such as extremity, craniomaxillofacial, vascularized composite allograft, and genitourinary/lower abdomen reconstruction. Projects must directly address the healthcare needs of military service members and veterans, demonstrating clear military relevance. Funding cannot be utilized for preclinical research studies. While the proposed clinical trials must align with these specified focus areas and military relevance, conducting trials solely with military populations is not a requirement. This initiative aims to translate promising regenerative therapies into clinical applications for those who have served.
Opportunity ID: 245713
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-14-DMRDP-CRMRP–RMCTA |
| Funding Opportunity Title: | Clinical and Rehabilitative Medicine Research Program Regenerative Medicine Clinical Trial Award |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 5 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Oct 28, 2013 |
| Last Updated Date: | Oct 28, 2013 |
| Original Closing Date for Applications: | Feb 11, 2014 |
| Current Closing Date for Applications: | Feb 11, 2014 |
| Archive Date: | Mar 13, 2014 |
| Estimated Total Program Funding: | $11,100,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: | The FY14 DMRDP CRMRP Regenerative Medicine Clinical Trial Award (RMCTA) is intended to support Phase I or II clinical trials focused on extremity regeneration, craniomaxillofacial regeneration, vascularized composite allografts, and/or genitourinary/lower abdomen reconstruction. Funding from this award mechanism cannot be used for preclinical research studies. All clinical trials must be responsive to the health care needs of military service members and veterans, and all applications must specifically and clearly address the military relevance of the proposed research; however, the use of military populations in the proposed clinical trial(s) is not a requirement. Applications submitted to the FY14 DMRDP CRMRP RMCTA must specifically address one or more of the focus areas listed below.-Extremity Regeneration -Craniomaxillofacial Regeneration-Vascularized Composite Allotransplantation (VCA)-Genitourinary/Lower Abdomen Reconstruction |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Phone 301-682-5507
Email:help@cdmrp.org |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
| Contact change. | Oct 28, 2013 | |
| Oct 28, 2013 |
DISPLAYING: Synopsis 2
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-14-DMRDP-CRMRP–RMCTA |
| Funding Opportunity Title: | Clinical and Rehabilitative Medicine Research Program Regenerative Medicine Clinical Trial Award |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 5 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Oct 28, 2013 |
| Last Updated Date: | Oct 28, 2013 |
| Original Closing Date for Applications: | Feb 11, 2014 |
| Current Closing Date for Applications: | Feb 11, 2014 |
| Archive Date: | Mar 13, 2014 |
| Estimated Total Program Funding: | $11,100,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: | The FY14 DMRDP CRMRP Regenerative Medicine Clinical Trial Award (RMCTA) is intended to support Phase I or II clinical trials focused on extremity regeneration, craniomaxillofacial regeneration, vascularized composite allografts, and/or genitourinary/lower abdomen reconstruction. Funding from this award mechanism cannot be used for preclinical research studies. All clinical trials must be responsive to the health care needs of military service members and veterans, and all applications must specifically and clearly address the military relevance of the proposed research; however, the use of military populations in the proposed clinical trial(s) is not a requirement. Applications submitted to the FY14 DMRDP CRMRP RMCTA must specifically address one or more of the focus areas listed below.-Extremity Regeneration -Craniomaxillofacial Regeneration-Vascularized Composite Allotransplantation (VCA)-Genitourinary/Lower Abdomen Reconstruction |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Phone 301-682-5507
Email:help@cdmrp.org |
DISPLAYING: Synopsis 1
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-14-DMRDP-CRMRP–RMCTA |
| Funding Opportunity Title: | Clinical and Rehabilitative Medicine Research Program Regenerative Medicine Clinical Trial Award |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 5 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Oct 28, 2013 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Feb 11, 2014 |
| Archive Date: | Mar 13, 2014 |
| Estimated Total Program Funding: | $11,100,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: | The FY14 DMRDP CRMRP Regenerative Medicine Clinical Trial Award (RMCTA) is intended to support Phase I or II clinical trials focused on extremity regeneration, craniomaxillofacial regeneration, vascularized composite allografts, and/or genitourinary/lower abdomen reconstruction. Funding from this award mechanism cannot be used for preclinical research studies. All clinical trials must be responsive to the health care needs of military service members and veterans, and all applications must specifically and clearly address the military relevance of the proposed research; however, the use of military populations in the proposed clinical trial(s) is not a requirement. Applications submitted to the FY14 DMRDP CRMRP RMCTA must specifically address one or more of the focus areas listed below. -Extremity Regeneration -Craniomaxillofacial Regeneration -Vascularized Composite Allotransplantation (VCA) -Genitourinary/Lower Abdomen Reconstruction |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Blossom Widder
Contract Specialist Phone 301-619-7143 Email:blossom.widder@us.army.mil |
Related Documents
Folder 245713 Full Announcement-1 -> fy13-14_ind-ide form.pdf
Folder 245713 Full Announcement-1 -> fy14 crmrp rmcta pa_gg.pdf
Folder 245713 Full Announcement-1 -> fy14 cdmrp gai – rmcta.pdf
Packages
| Agency Contact Information: | Phone 301-682-5507 Email: help@cdmrp.org |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 12.420 | PKG00187870 | Oct 28, 2013 | Feb 11, 2014 | View |
Package 1
Mandatory forms
245713 RR_SF424_1_2-1.2.pdf
245713 PerformanceSite_1_4-1.4.pdf
245713 RR_Budget-1.1.pdf
245713 RR_KeyPersonExpanded_1_2-1.2.pdf
Optional forms
245713 RR_SubawardBudget30-1.2.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
